Viridian Therapeutics, Inc. · NASDAQ:VRDN
Deep Track Capital, LP's stake in Viridian Therapeutics, Inc. fell to 3.25% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Deep Track Capital, LP's stake in Viridian Therapeutics, Inc. fell to 3.25%, 3,592,740 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 3.25%
- Shares
- 3,592,740
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 3.25% | 3,592,740 |
| Deep Track Biotechnology Master Fund, Ltd. | 3.25% | 3,592,740 |
| David Kroin | 3.25% | 3,592,740 |
Source
Related
- Viridian Therapeutics, Inc.
- Deep Track Capital, LP
- Viridian Therapeutics, Inc. shareholders
- Schedule 13G · Deep Track Capital, LP · May 8, 2026
- Schedule 13G/A · Deep Track Capital, LP · Feb 13, 2026
- Form 4 · Tousignant Jennifer · Aug 20, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Aug 20, 2026
- Form 4 · Tripuraneni Radhika · Aug 18, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Paradigm Biocapital Advisors LP · Aug 14, 2026